Investor Presentaiton

Syngene strengths A global scale CRO/CDMO • • • Integrated Drug Discovery, Development and Manufacturing service provider Small and large molecules, ADCs, oligonucleotides Listed on Indian Stock Exchanges (NSE and BSE) Syngene $ Solutions through innovation • IP fully assigned to clients • • Track record of data management and security Over 400+ patent filings by clients recognizing Syngene scientists Science in our DNA • • • Located in 3 top India life science hubs: Bangalore, Mangalore and Hyderabad ~6000+ qualified scientists including ~500 PhDs (~6,000+ total headcount) Resilient supply chain management 2 Mn+ sq. ft. world-class R&D and manufacturing infrastructure 888 Quality matters Fully digitized quality organization • Strong compliance track record with global regulators • • US FDA, EMA and PMDA approved, GLP certified, AAALAC accredited facilities 78 client and regulator audits in the last financial year Blue chip client list + 400+ active clients • • . Partnering with large / mid-size / emerging biopharma and other industries Clients concentrated in US, Europe & Japan Track record of working with diverse industry sectors Making a difference • Partnerships have delivered numerous clinical candidates Delivery history for integrated CMC programs up to clinical trials and beyond Putting Science to Work 15

View entire presentation